SCHEMBL7734065

SCHEMBL7734065

CC(C)(C)OC(=O)N1C[C@H](N(C(=O)CN)C(=O)OC(C)(C)C)C[C@H]1C(=O)Nc1nc(-c2ccccc2)cs1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.49
ALDH1A1 P00352 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 2/20 0.47
PARP1 P09874 1/20 0.42
CNR2 P34972 1/20 0.41
MAPT P10636 4/20 0.41
USP2 O75604 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KCNQ1 P51787 1/20 0.41
USP30 Q70CQ3 2/20 0.40
NPC1 O15118 3/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
KDM4E B2RXH2 1/20 0.39
S1PR2 O95136 1/20 0.39
NR2F2 P24468 1/20 0.39
HTT P42858 1/20 0.39
ELOVL1 Q9BW60 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7731725 0.81 HDAC8 (0.44) MAPTNPC1
SCHEMBL7726523 0.79 HDAC8 (0.41) LMNAUSP30NPC1KDM4E
SCHEMBL7731479 0.79 HDAC8 (0.44) ALDH1A1SMN1; SMN2LMNANPC1KDM4E
SCHEMBL7729236 0.78 HDAC4 (0.41) RAB9ASMN1; SMN2LMNAMAPTHSD17B10
SCHEMBL9892928 0.77 SMN1; SMN2 (0.56) UCHL1ALDH1A1RAB9ASMN1; SMN2LMNA
SCHEMBL7728192 0.77 POLB (0.47) ALDH1A1NPC1
SCHEMBL7725709 0.77 NPC1 (0.43) MAPTNPC1
SCHEMBL7727252 0.77 KDM4E (0.46) ALDH1A1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL7734064 0.76 RAB9A (0.47) UCHL1ALDH1A1RAB9ASMN1; SMN2LMNA
SCHEMBL13257794 0.75 KCNQ1 (0.65) UCHL1ALDH1A1RAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed